Ajmera Realty Q2 Results: Net Profit Falls 33%, Sales Value Rises 52%
Ajmera Realty Ltd. on Wednesday reported a 33% decline in consolidated net profit for the September quarter.
The real estate major's sales by value rose 52% year-on-year, while the number of units sold went up by 51% YoY, respectively. The growth was driven by the continued sales momentum of the Ajmera Eden launch, along with contribution from Manhattan and robust demand across other projects, the company said in an exchange filing.
Ajmera Realty Q2 YoY:
Revenue down 21.6% at Rs 145 crore vs Rs 185.5 crore
Ebitda down 32.7% at Rs 38 crore vs Rs 56 crore
Margin at 25.9% vs 30.2%
Net profit down 33% at Rs 23 crore vs Rs 34 crore
Other Highlights
Sales Volume stood at 1,20,787 sq. ft, up 51% YoY
Sales Value stood at Rs 252 crore, up 52% YoY
Company said it has reached halfway to its sales target of Rs 1,000 crore for FY24
"Despite the ongoing business development activities, the debt-to-equity ratio remains stable at 0.97 times for Q2 FY24, similar to the trailing quarter, thus sustaining the ratio below 1 times ratio of net worth. Also, the weighted average cost of debt was 12.1% at the end of quarter," the company said in a statement.
Ajmera Realty said it has expanded launch pipeline includes 7 projects admeasuring 1.3 mn sq.ft. of potential development with estimated gross development value of Rs 2,750 crore.
"With an expansive launch pipeline & sales development potential of ~1.3 million square feet, our revenue visibility has now expanded to around Rs 4,750 crore from our ongoing projects and future launches," said Dhaval Ajmera, Director.
Shares of Ajmera Realty Ltd fell 0.8% at Rs 378 apiece on the BSE in Wednesday's afternoon session after the earnings announcement as compared to 0.2% fall in BSE Sensex.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.